From: A content analysis of internet information sources on medical cannabis
Condition | Percent | NASEM conclusion |
---|---|---|
Nausea (including from chemotherapy) | 26 | Conclusive or substantial |
Pain | 24 | (no conclusion) |
Epilepsy | 23 | None or insufficient |
Multiple sclerosis | 21 | Conclusive or substantial |
Chronic pain | 20 | Conclusive or substantial |
Anxiety | 20 | Limited |
Appetite loss | 19 | Limited |
Cancer | 19 | None or insufficient |
Glaucoma/Intraocular pressure | 15 | Ineffective (limited) |
Depression | 14 | Ineffective (limited) |
Vomiting (including from chemotherapy) | 14 | Conclusive or substantial |
Chronic Fatigue Syndrome | 13 | (no conclusion) |
Insomnia | 13 | (no conclusion) |
PTSD | 13 | Limited |
Neuropathic pain | 11 | (no conclusion) |
Arthritis (including various forms) | 10 | (no conclusion) |
Inflammation | 10 | Limited |
HIV/AIDS | 10 | None or insufficient |
Muscle spasms | 10 | (no conclusion) |
Drug and alcohol addiction | 9 | Increased risk (moderate) |